Publications by authors named "A Burmester"

(.) ITS genotype VIII, also known as , is a new species of the / complex and its first records, albeit under a different species name, are from the Indian subcontinent, Middle Eastern Asia, and West Asia genotype VIII (. ) has spread globally and has now been documented in over 30 countries.

View Article and Find Full Text PDF

is an emerging pathogen causing recalcitrant skin infections and exhibiting multiple resistances to azoles and allylamines. Squalene epoxidase mutants often show association with azole resistance. RT-PCR gene expression analysis helps to elucidate the connection between ergosterol biosynthesis regulation and efflux control through the activation of multidrug resistance (MDR) and major facilitator superfamily (MFS1) transporters as well as heat shock proteins (HSP).

View Article and Find Full Text PDF

Background: Emerging evidence suggests that traumatic brain injury (TBI) is a major risk factor for developing neurodegenerative disease later in life. Quantitative susceptibility mapping (QSM) has been used by an increasing number of studies in investigations of pathophysiological changes in TBI. However, generating artefact-free quantitative susceptibility maps in brains with large focal lesions, as in the case of moderate-to-severe TBI (ms-TBI), is particularly challenging.

View Article and Find Full Text PDF
Article Synopsis
  • - A new genotype of the causative agent of mouse favus has emerged, showing a significant increase in itraconazole resistance and peaking in infections around 2020 in Jena, Thuringia.
  • - The strains from Thuringia differ genetically from those in the IHEM collection, particularly in the ITS region and exhibit a unique amino acid change associated with their drug resistance.
  • - The resistance traits may have developed through interspecies mating, suggested by nearly identical mating type fragments, while also demonstrating increased genetic diversity in related protein sequences.
View Article and Find Full Text PDF

For more than 30 years, an 82-year-old man has been suffering from tinea corporis generalisata in the sense of Trichophyton rubrum syndrome. The patient received long-term treatment with terbinafine. Fluconazole had no effect.

View Article and Find Full Text PDF